We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
28 Oct 2025 - Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide contract […]
Read moreCapacity expansion underway at our Ambernath facility
24 Oct 2025 - We recently announced an investment at our Ambernath facility in India—transforming it into a larger, more diverse site. This expansion is part of PolyPeptide’s strategic growth, […]
Read moreCapacity expansion for major Pharma’s hormonal disorders and women’s health portfolio
29 Sep 2025 - We recently announced a capacity expansion at our Braine-l’Alleud site in Belgium, strategically backed by customer financing. This investment underscores our commitment to capturing growth in […]
Read moreAlzinova testimonial: Alzheimer’s peptide vaccine with PolyPeptide
1 Sep 2025 - September is International Alzheimer’s Month, a reminder of the urgent need to advance research and treatment options for patients and families affected worldwide. It is an […]
Read moreAlzinova Advances ALZ-101 Development with Drug Substance Release, Paving the Way for Phase 2 Clinical Trial
24 Apr 2025 - Sweden, 24 April 2025 – Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical […]
Read moreVinnova grant awarded to joint project between PolyPeptide and Red Glead Discovery for developing a more sustainable manufacturing method for a GLP-1 agonist.
27 Aug 2024 - PolyPeptide in Limhamn, Sweden and Red Glead Discovery in Lund, Sweden have joined forces to pursue the development of a more sustainable manufacturing method for a […]
Read morePolyPeptide launches new “Innovation Lab”
8 May 2023 - Strasbourg, France, 8 May 2023 – To support its strategic ambitions, PolyPeptide relocated and expanded its Innovation Lab in Strasbourg. The Group’s central innovation team under […]
Read moreFluoGuide reaches milestone with FG001 for phase III clinical supply
9 Nov 2022 - “We are thankful for the opportunity to work with FluoGuide on the highly innovative FG001 project and congratulate the whole team for reaching this milestone.”
Read morePolyPeptide wins Malmö Life Science Business Award
28 Jun 2022 - Malmö, 21 June 2022 We are proud of our site in Malmö, Sweden, for winning the Life Science Business Award of the city (Malmö Näringslivspris Life […]
Read more